Heart Test Laboratories, Inc. Presents Clinical Trials at American Heart Association

    COLLEYVILLE, TX, August 19, 2011 /24-7PressRelease/ -- Heart Test Laboratories, Inc. is pleased to announce the acceptance of Dr. Partho Sengupta's clinical results to present in the upcoming American Heart Association's Scientific Sessions in November.

With over 17,000 professionals attending annually, AHA's Scientific Sessions is the world's largest gathering of scientists and healthcare professionals devoted to the science of cardiovascular disease, stroke, and the care of patients suffering from these diseases.

Dr. Sengupta, current associate professor of medicine at Mount Sinai Heart, with Dr. Giuseppe Caracciolo, also with Mount Sinai Heart, will present their results on their Indian Clinical Trial entitled "Assessment of T-wave Morphology by Signal Processed Body Surface Electrocardiographic Potential Mapping Predicts Subclinical Left Ventricular Dysfunction in Patients with Systemic Hypertension."

Dr. Sengupta with his staff conducted the trial in association with the University of California, Irvine prior to coming on staff recently at Mount Sinai.

"This is a pivotal development for the exposure of Heart Test Laboratories and the MyoVista" says Drew Diaz CEO. "This will add much more visibility to the technology and validate the progress of the company."

Heart Test Laboratories, Inc. is in the final stages of releasing the MyoVista , a portable, affordable, diagnostic test used to determine the presence and level of life threatening myocardial abnormalities.

For more information, please contact Drew Diaz at (817) 307-4848 or visit www.HeartTestLabs.com.

# # #